Dascena, Inc., a machine learning algorithm company that is targeting early disease intervention to improve patient care outcomes, today announced that Andrew Pucher has been appointed as Chief Financial Officer. Mr. Pucher brings extensive experience in capital markets, financing, and public company operations to Dascena.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210406005094/en/
Dascena Appoints Andrew Pucher as Chief Financial Officer. (Photo: Business Wire)
“As Dascena continues to grow, the strength of our team is of the utmost importance. We are thrilled to welcome Andrew to Dascena, whose combination of deep capital markets and operating experience will be key to supporting the commercialization of our predictive algorithms across multiple healthcare markets,” said Ritankar Das, Founder and Chief Executive Officer of Dascena.
“I’ve been impressed with the progress that Dascena has made on the real-world application and commercialization of its machine learning predictive algorithm platform,” said Mr. Pucher. “Our algorithms have the potential to significantly impact how patient care is managed, and ultimately transform patient outcomes. I look forward to partnering with the team at Dascena to deliver value to patients and our shareholders.”
Mr. Pucher joins Dascena from Tilray, Inc. where he served as Chief Corporate Development Officer through the company’s announced sale for $1.4 billion. Previously, Mr. Pucher was a Managing Director at Goldman Sachs, where he served as a senior leader within the investment bank’s Global Healthcare Group in New York City, as well as the Canadian Investment Banking franchise. Over the course of his career at Goldman Sachs, Mr. Pucher advised on more than $200 billion in M&A and financing transactions across the healthcare sector. Mr. Pucher holds a BBA from Simon Fraser University and JD/MBA from York University.
Dascena is developing machine learning diagnostic algorithms to enable early disease intervention and improve care outcomes for patients. For more information, visit dascena.com